Skip to main content
. 2020 Feb 5;115(7):1295–1305. doi: 10.1111/add.14941

Figure 2.

Figure 2

Participants’ reports of the extent to which different features of treatment with XR‐buprenorphine injections raised problems or concerns (%). [Colour figure can be viewed at wileyonlinelibrary.com]